Research

Cellular

In psoriasis, 4 of 5 clinical studies demonstrated significant improvements in Psoriasis Area Severity Index and weight/body mass index.

GLP-1 receptor agonists may significantly improve psoriasis severity and contribute to weight loss.

StrongSupportsmedium confidence
In psoriasis, 4 of 5 clinical studies demonstrated significant improvements in Psoriasis Area Severity Index and weight/body mass index.
Derin Karacabeyli et al. · JCR Journal of Clinical Rheumatology · 2023

Why this rating

The claim is based on findings from multiple clinical studies.

Source

Glucagon-Like Peptide 1 Receptor Agonists in Patients With Inflammatory Arthritis or Psoriasis

Derin Karacabeyli et al. · JCR Journal of Clinical Rheumatology · 2023

DOI 10.1097/rhu.0000000000001949

review · n=19Cited 51×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →